Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 521871Generated: October 30, 2026

Diisopropylethylamine → tert-butyl N-[2-bromo-4-[[5-[2-(tert-butoxycarbonylamino)-8-oxabicyclo[3.2.1]octan-5-yl]-1-methyl-pyrazol-4-yl]carbamoyl]thiazol-5-yl]carbamate

https://huagongshe.com/reaction/521871

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDiisopropylethylamineHCID 81531—
ReactantPyBOPHCID 2724699—
Reactant2-Bromo-5-((tert-butoxycarbonyl)amino)thiazole-4-carboxylic acidHCID 58182156—
Reactanttert-butyl N-(5-fluoro-2-hydroxy-5-(2-methyl-4-nitro-pyrazol-3-yl)cycloheptyl)carbamateHCID 86713008—
ReactantHCID 178418361HCID 178418361—
CatalystPalladiumHCID 23938—
SolventMethanolHCID 887—
SolventWaterHCID 962—
SolventDichloromethaneHCID 6344—
SolventTetrahydrofuranHCID 8028—
Producttert-butyl N-[2-bromo-4-[[5-[2-(tert-butoxycarbonylamino)-8-oxabicyclo[3.2.1]octan-5-yl]-1-methyl-pyrazol-4-yl]carbamoyl]thiazol-5-yl]carbamateHCID 8671381934%

Reaction Steps

To a solution of tert-butyl N-[5-fluoro-2-hydroxy-5-(2-methyl-4-nitro-pyrazol-3-yl)cycloheptyl]carbamate (210 mg, 0.565 mmol, intermediate 64) in THF (20 mL) and MeOH (20 mL) was added 10% palladium on carbon (20 mg). The reaction mixture was heated at 40° C. under a 400 psi atmosphere of hydrogen for 3 hr. After cooling to room temperature, the mixture was filtered through Celite®, washing with MeOH (50 mL) and concentrated under reduced pressure. To a solution of the residue in DCM (30 mL) was added DIPEA (2 mL, 1.40 mmol), 2-bromo-5-(tert-butoxycarbonylamino)thiazole-4-carboxylic acid (208 mg, 0.62 mmol, Example 22) and PyBOP (727 mg, 1.40 mmol) and the mixture was stirred at room temperature for 18 hr. Water (20 mL) was added and the mixture was extracted with DCM (100 mL). The organic layer was passed through a phase separation cartridge and concentrated under reduced pressure. Purification via silica gel chromatography (80-100% EtOAc/isohexane) gave tert-butyl N-[2-bromo-4-[[5-[2-(tert-butoxycarbonylamino)-8-oxabicyclo[3.2.1]octan-5-yl]-1-methyl-pyrazol-4-yl]carbamoyl]thiazol-5-yl]carbamate (120 mg, 34% over two steps). 1H NMR (400 MHz, CDCl3) δ 10.40 (br s, 1H), 9.86 (br s, 1H), 8.12 (br s, 1H), 4.70-4.63 (m, 1H), 4.36-4.22 (m, 1H), 3.97-3.86 (m, 1H), 3.86 (s, 3H), 2.40-2.31 (m, 1H), 2.21-1.93 (m, 7H), 1.55 (s, 9H), 1.52 (s, 9H).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09328106B2
Source datasetuspto-grants-2016_05
ORD IDord-ceb30ea113db47759825c663b6b0c634
Source noteuspto-grants-2016_05